3D Fibrous Scaffold Microarchitecture for Stem Cell Phenotype Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current stem cell expansion and differentiation methods on two-dimensional substrates result in low yields, purity, and homogeneity issues, with existing screening techniques relying on bulk measurements and large cell populations, leading to significant challenges in regenerative medicine.
Innovation Solution
A method for precision manufacturing of three-dimensional biomaterial scaffolds using melt electrowriting (MEW) to create porous microarchitectures, allowing homogeneous stem cell expansion and targeted differentiation without bioactive molecules, combined with machine learning for phenotype classification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If two-dimensional substrates with bioactive reagents are used for stem cell expansion, then stem cell phenotype can be conserved or modified, but stem cell purity and homogeneity deteriorate and yields become low
Solution Approach 1:
The patent transitions from two-dimensional substrates to three-dimensional scaffolds with controlled porous microarchitectures. This dimensional change allows stem cells to maintain their phenotype while improving purity and homogeneity through spatial organization and controlled cell-environment interactions within the 3D structure.
Solution Approach 2:
The patent introduces local quality control through precisely engineered porous microarchitectures with specific pore sizes, shapes, and distributions. These local structural features create controlled micro-environments that guide stem cell behavior, phenotype consistency, and homogeneity without requiring bulk bioactive reagents.
2Productivity
If bulk measurements and large stem cell populations are used for phenotype screening, then screening can be performed, but measurement precision and cell population homogeneity deteriorate
Solution Approach 1:
The patent segments the stem cell population into individually resolvable units within the 3D scaffold structure. Each cell or small cell group can be independently monitored and classified through high-resolution imaging, enabling precise phenotype screening without requiring bulk measurements of large cell populations.
Solution Approach 2:
The patent replaces bulk mechanical/chemical measurement methods with optical imaging and machine learning-based classification. High-resolution confocal microscopy and automated image analysis algorithms enable precise phenotype screening at the single-cell level, eliminating the need for bulk measurements that compromise precision.
3Ease of manufacture
If conventional additive manufacturing is used for scaffold fabrication, then manufacturing can be performed, but manufacturing precision for microscale geometrical features deteriorates
Solution Approach 1:
The patent replaces conventional mechanical additive manufacturing with electrohydrodynamic printing. This field-based manufacturing process uses electric fields to precisely control material deposition, enabling accurate fabrication of microscale geometrical features (10-100 μm) while maintaining ease of manufacture through automated programming.
Solution Approach 2:
The patent changes the manufacturing parameter control mechanism from mechanical to electrohydrodynamic. By adjusting voltage, flow rate, and other EHD parameters, precise control over fiber diameter, pore size, and microarchitectural features is achieved, pushing the resolution limit of additive manufacturing for biological applications.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Achieves high-fidelity, homogeneous stem cell expansion and targeted differentiation, preserving stem cell phenotype for extended periods, and enabling reproducible harvesting of targeted populations.
Implementation Method 1
high-fidelity fibrous scaffolds are fabricated through electrohydrodynamic (EHD) printing of a biopolymer melt using a melt electrowriting ('MEW') technique
Data Source
AI summary
Methods for the development and integration of multiple apparatuses and methods for achieving administration of stem cell therapies include precision manufacturing of tissue scaffolds and/or bioreactor substrates. The nano/microscale fiber material extrusion typifying the electrospinning process is married with the fiber alignment and layering characteristic of an additive manufacturing process. The method generates porous fibrous 3-D meshes with precision controlled structures from biopolymer melts and solutions and gels, blends, and suspensions with and without cells. A method of tracking the migration histories and shapes of stem cells on scaffold surfaces relies on immunofluorescent imaging and automated algorithms based on machine learning. The combination of the precision manufacturing method and the method of cell tracking and cell shape statistics, along with understanding of the intimate relationship between the cell shape/phenotype and scaffold architecture leads to an integrated method for cultivating and harvesting cells having desired phenotypes.